Minrad
Medical Equipment ManufacturingUnited States51-200 Employees
Minrad operates in the medical equipment manufacturing sector in the United States, with a focus on providing injectable and critical care products through its parent brand, Piramal Critical Care. The company’s portfolio includes a range of injectable medications used in acute and intensive care settings, expanding its offerings through periods of product launches to broaden the scope of generic injectables available in the U.S. market. Its customer base comprises healthcare providers and facilities that require ready-to-use intravenous therapies for critical care, with product introductions aimed at enhancing treatment options in hospital environments. Based in the United States and part of Piramal Pharma’s critical care division, Minrad situates itself within the broader life sciences equipment and pharmaceutical supply chain, contributing to the availability of essential injectable medications. A notable recent development involves the launch of Edaravone IV Infusion and other injectables, reflecting ongoing portfolio expansion in the critical care space. Although specific market metrics are not disclosed, the company operates with a size indicative of a mid-sized organization within the medical equipment manufacturing landscape.